A short, evidence-grounded conversation about TET enzymes and its place in longevity science.
Speaker 1
...and this is why α-Ketoglutarate, or α-KG, has been generating so much buzz. It’s a cofactor for TET enzymes, which are α-KG-dependent DNA demethylases.
Speaker 2
Right, and those TET enzymes are fascinating because they remove methyl marks from DNA, essentially remodeling the epigenetic clock. So, the theory is that by supplementing α-KG, you could potentially boost TET activity and influence aging pathways.
Speaker 1
Exactly. There's compelling evidence in animal models. For instance, a study in Cell Metabolism in 2020 showed that α-KG supplementation extended lifespan and healthspan in mice. But that’s mice, not humans.
Speaker 2
And that’s the crucial distinction, isn't it? When we look at human data, specifically clinical trials, the picture becomes a lot less clear. While α-KG is generally considered safe, and it's involved in the TCA cycle for energy production, demonstrating direct epigenetic benefits in humans through supplementation has been challenging.
Speaker 1
Absolutely. Many human trials exploring α-KG's impact on markers of aging, like epigenetic clock changes, haven't yielded statistically significant results yet. We see a lot of null results, meaning no measurable effect, or very subtle changes that might not translate to meaningful health outcomes.
Speaker 2
So, while the mechanistic understanding and animal data are exciting, human evidence for α-KG directly impacting the epigenetic clock or extending human healthspan through supplementation is still largely unproven. It highlights the gap between theory and what clinical trials actually show.
Educational research discussion only — not medical advice. Statements have not been
evaluated by the FDA. Nothing here is intended to diagnose, treat, cure or prevent any disease.
Talk to a qualified clinician before changing any treatment.